Our research involves the application of nutrition and nutrigenetics to the nutraceutical prevention and post-onset management of type 2 diabetes in humans, with a view to the reduction of polypharmacy.
Operates across research disciplines to bring cutting-edge expertise, resources and opportunities to companies and organizations in the digital health technology sector